Volastra
Jacqueline has over 22 years of experience between corporate business and academia. In the last 15 years she has focused on supporting C-level executives. She takes great pride in her ability to juggle multiple responsibilities, her strong organizational skills, and great eye for detail while providing excellent customer service. Prior to joining Volastra, Jacqueline was at Weill Cornell Medicine where she supported their Founder, Lewis Cantley, Ph.D. for almost 9 years. Jacqueline worked closely with various groups within Cornell which included the Dean’s office, the Development office in supporting confidential philanthropic efforts as well as media relations, making sure all interviews were handled in accordance with Cornell’s rules. While under Dr. Cantley’s leadership, Jacqueline assisted in all recruitment efforts, hiring highly regarded junior and senior leadership personnel in the medical and scientific world. Jacqueline attended Westchester Community College as well as the School of Visual Arts where she pursued various acting and film studies.
This person is not in any teams
This person is not in any offices
Volastra
1 followers
Volastra Therapeutics, Inc., is developing novel therapies to treat and prevent the formation of metastatic disease. Launched from the laboratory of Dr. Lewis Cantley, along with Drs. Olivier Elemento and Samuel Bakhoum, Volastra has identified the mechanisms by which CIN drives the formation and proliferation of metastases. Following initial evidence that a patient’s CIN status is prognostic for metastasis and that CIN alters metastasis and overall survival in mouse models, the company is discovering mechanisms and pathways by which CIN modulates metastatic disease to develop novel therapeutics.